sRAGE and early signs of cardiac target organ damage in mild hypertensives

BACKGROUND: Soluble Receptor for Advanced Glycation End Products (sRAGE) may be considered a marker inversely related to inflammation and its participation has been established in patients with advanced atherosclerotic vascular diseases. However, it is still unknown whether sRAGE reduction could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Maresca, Andrea Maria, Guasti, Luigina, Bozzini, Sara, Mongiardi, Christian, Tandurella, Nicolò, Corso, Rossana, Zerba, Francesco G., Squizzato, Alessandro, Campiotti, Leonardo, Dentali, Francesco, Klersy, Catherine, Grandi, Anna M., Falcone, Colomba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371567/
https://www.ncbi.nlm.nih.gov/pubmed/30755202
http://dx.doi.org/10.1186/s12933-019-0821-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371567/
https://www.ncbi.nlm.nih.gov/pubmed/30755202
http://dx.doi.org/10.1186/s12933-019-0821-5

Ejemplares similares